The Sarah Cannon Transplant & Cellular Therapy Network offers patients convenient, community-based access to complex blood cancer care, hematopoietic cell transplant (HCT) (sometimes called blood and marrow transplant), clinical trials, and innovative therapies such as immune effector cell therapy (IECT). The Network also provides care for those facing blood disorders and other immune-related disorders.

The Sarah Cannon Transplant & Cellular Therapy Network is the largest cellular therapy network performing HCT and IECT and treats 1,600 transplant and cellular therapy patients annually across its nine FACT/JACIE accredited programs located throughout the United States and United Kingdom.

The Network delivers cutting-edge treatments and therapies to patients in communities close to home and cares for tens of thousands of patients each year, more than any academic medical center. Each Sarah Cannon Transplant & Cellular Therapy Network program features a specialized team committed to the care of complex blood cancers and other disorders and includes expert physicians, advanced practice providers, nurses, registered dieticians, physical/occupational therapists, social workers, financial coordinators, nurse navigators and HCT coordinators ensuring care for the whole patient throughout the care journey. The network’s integration of research, quality, training and technology ensures patients access to the highest standards of care.

Our Hematopoietic Cell Transplant (HCT) Program

Sarah Cannon is one of the world’s largest providers of hematopoietic cell transplant, treating approximately 1,600 transplant and cellular therapy patients annually. The experience of our centers is reflected in the 16,000+ transplants performed since inception. In fact, recent data shows the Sarah Cannon Transplant & Cellular Therapy Network is the largest provider of HCTs in the United States, tracking ahead of all major academic medical centers and networks.

What We Treat

Sarah Cannon Transplant and Cellular Therapy Network Locations & Services

Sarah Cannon Market Hematopoietic Cell Transplant (HCT) Program HCT Transplant Types Immune Effector Cell Therapy
Austin Sarah Cannon Transplant and Cellular Therapy Program at St. David’s South Austin Medical Center Adult Autologous and Allogeneic Transplants - Related/ Unrelated/ Haploidentical FDA Approved and Research Options
Dallas Blood Cancer Center
Blood & Marrow Transplant Program
Medical City Dallas		 Adult and Pediatric Autologous, Allogeneic - Related/ Unrelated/ Haploidentical/ UCB FDA Approved Options
Denver Colorado Blood Cancer Institute (CBCI), a part of the Sarah Cannon Cancer Institute at Presbyterian/St. Luke’s Medical Center Adult and Pediatric Autologous, Allogeneic - Related/ Unrelated/ Haploidential/ UCB ++CBCI also offers services for auto immune disorders FDA Approved and Research Options
Gainesville HCA Florida North Florida Hospital
Las Vegas Sarah Cannon Transplant and Cellular Therapy Program at MountainView Hospital Adult Autologous NA
London HCA Healthcare UK at University College Hospital, Private Care (London), Private Care at Guy’s at London Bridge Hospital (London) Adult FDA Approved and Research Options
Manchester The Christie Private Care, part of HCA Healthcare UK (Manchester) Adult FDA-Approved Options
Nashville Sarah Cannon Transplant and Cellular Therapy Program at TriStar Centennial Adult and Pediatric Autologous, Allogeneic - Related/ Unrelated/ Haploidentical FDA Approved and Research Options
San Antonio Sarah Cannon Transplant and Cellular Therapy Program at Methodist Hospital, San Antonio Adult and Pediatric Autologous, Allogeneic - Related/ Unrelated/ Haploidentical/ UCB FDA Approved and Research Options